
Stryker Corporation (SYK) – Strong presence in orthopaedic industry
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on October 7, 2022This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.
Stryker Corporation (SYK)
Stryker has a diversified product portfolio. It has a wide range of products which shields the company against any significant sales shortfall. Its significant exposure to robotics, artificial intelligence for health care and Medical Mechatronics has helped the company stay ahead of the curve in the MedTech space.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– CrispIdea Segment Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– PE Band Comparison
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals
Peer Performance
– Summary
– Profitability
– Growth
– Price Performance
Ownership
Stock Price Performance
Crispidea Coverage
No of Pages : 36